Henshaw Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
BG
Henshaw Capital's BSX Position: Q4 2022 in Review
Henshaw Capital sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 9,920 shares — an estimated $384K sold.
Henshaw Capital first reported a position in BSX in Q1 2018 and held it in 19 quarters. The position peaked at $729K in Q3 2020. 930 funds tracked by Wall St. Rank hold BSX as of Q4 2022.
- Henshaw Capital reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
- Henshaw Capital sold 9,920 Boston Scientific shares in Q4 2022, an estimated $384K.
- Henshaw Capital first reported a position in Boston Scientific in Q1 2018 and held it in 19 quarters.
- Henshaw Capital's Boston Scientific position peaked at $729K in Q3 2020.
- 930 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.
Based on Henshaw Capital's 13F filing for Q4 2022, filed 28 May 2026.